ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Obesity Predicts New-Onset Diabetes After Live Kidney Donation.

    K. Lentine,1 A. Naik,2 N. Lam,3 M. Schnitzler,1,6 H. Xiao,1 D. Axelrod,4 G. Hess,5 B. Kasiske,6 A. Garg,7 S. Gustafson,6 D. Brennan,8 D. Segev.9,6

    1St. Louis Univ, St. Louis; 2U Michigan, Ann Arbor; 3U Alberta, Edmonton, Canada; 4E Carolina Univ, Greenville; 5Symphony Health, Philadelphia; 6Scientific Registry of Transplant Recipients, Minneapolis; 7Western Univ, London, Canada; 8Washington Univ, St. Louis; 9Johns Hopkins, Baltimore

    End-stage renal disease is uncommon in living kidney donors (LKD), but recent data suggest that most kidney failure developing late after donation is due to…
  • 2017 American Transplant Congress

    Improving Value by Standardizing the Use of IVIG Amongst Pediatric Solid Organ Transplant (SOT) Patients.

    J. Sawyer,1 J. Bucuvalas,2 L. Danziger-Isakov,3 J. Gossett,3 L. Burkhart,3 A. Lorts.3

    1Division of Pharmacy, Cincinnati Children's Hospital Medical Center, Cincinnati; 2Division of Gastroenterology, Cincinnati Children's Hospital Medical Center, Cincinnati; 3Solid Organ Transplant Center, Cincinnati Children's Hospital Medical Center, Cincinnati

    Background: Given the high cost of pharmaceuticals (i.e. IVIG), we sought to determine if unnecessary variation in drug use may be an opportunity to improve…
  • 2017 American Transplant Congress

    Improving Donor Screening for Cytomegalovirus (CMV): Is CMV IgG Avidity Better Than CMV IgM?

    H. Prince,1 M. Nowicki.1,2

    1Donor Screening Laboratory, VRL Eurofins, Los Angeles, CA; 2Mendez National Institute of Transplantation Foundation, Los Angeles, CA

    Study purpose: It is standard practice to test organ donors for CMV IgM as a marker of recent CMV infection (defined as primary infection within…
  • 2017 American Transplant Congress

    Antiretroviral Therapy Modification of HIV+ Patients Listed for Kidney Transplantation.

    D. Lee,1 G. Malat,3 T. Bias,1 S. Epstein,1 L. Levin Mizrahi,2 M. Harhay,2 S. Talluri,2 K. Ranganna.2

    1Division of Infectious Diseases and HIV Medicine, Drexel University College of Medicine, Philadelphia; 2Division of Nephrology, Drexel University College of Medicine, Philadelphia; 3Department of Surgery, Drexel University College of Medicine, Philadelphia

    Introduction:HIV+ individuals can receive kidney transplant (KT) safely and effectively but face additional challenges from potential drug interactions between antiretroviral therapy (ART) and immunosuppression(IS). Little…
  • 2017 American Transplant Congress

    Differences in Kinetics of IFN-y Production Between Endogenous and Allotransplant-Induced Memory T Cells.

    B. Gonzalez-Nolasco, J. Marino, W. Orent, G. Benichou.

    Center for Transplantation Sciences, Massachusetts General Hospital / Harvard Medical School, Boston, MA

    Background:CD8+ memory T cells produce IFN-g in a faster and stronger fashion than their naïve counterparts after allorecognition. Unmanipulated mice possess a proportion of endogenous…
  • 2017 American Transplant Congress

    Mechanisms of Fibrosis in the Allograft Kidney: RNA-seq Based Analysis Using Formalin Fixed Biopsies.

    G. Zeng,2 L. Pan,1 Z. Lyu,1 Y. Huang,2 P. Randhawa.2

    1Department of Nephrology, Guangxi Medical University, Nanning, Guangxi, China; 2Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA

    Development of allograft fibrosis determines long term graft survival but our understanding of this important complication is incomplete. To gain further insight into this problem…
  • 2017 American Transplant Congress

    SIRPα+ DCs and the Time-Dependent CD4+CD8+ Double Positive T Cell Infiltration in Accepted Renal Allografts.

    T. Ashry,1,2 C. Yang,2 B. Jiang,2 D. Ndishabandi,2 P. Russel,1,2 R. Colvin,1,2 J. Madsen,1,2 A. Alessandrini.1,2

    1HMS, Boston; 2MGH, Boston

    IntroductionIn 2015 Overgaard and colleagues proposed that double positive T (DPT) cells, usually unique to the thymus, represent more than a developmental phase as extrathymic…
  • 2017 American Transplant Congress

    Impact of Complement Component 3 Single Nuclear Polymorphisms on Renal Transplant Recipients with Antibody-Mediated Rejection.

    Z. Wang, Z. Han, J. Tao, R. Tan, M. Gu.

    Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

    Impact of complement component 3 single nuclear polymorphisms on renal transplant recipients with antibody-mediated rejectionZijie Wang, Zhijian Han, Jun Tao, Ruoyun Tan, Min GuDepartment of…
  • 2017 American Transplant Congress

    Donor-Derived Cell-Free DNA Is a Dynamic Biomarker of Active Rejection in Kidney Allografts.

    D. Brennan,1 J. Bromberg,2 E. Poggio,3 D. Hiller,4 J. Sninsky,4 R. Woodward,4 J. Yee,4 R. Bloom.5

    1Washington University, St. Louis, MO; 2University of Maryland, Baltimore, MD; 3Cleveland Clinic, Cleveland, OH; 4CareDx, Brisbane, CA; 5University of Pennsylvania, Philadelphia, PA

    Purpose: Donor-derived cell-free DNA (dd-cfDNA) has shown promise as a biomarker in identification of allograft rejection. Here we report on the changes in dd-cfDNA prior…
  • 2017 American Transplant Congress

    Incidence and Clinical Outcomes of Mycobacterium tuberculosis Infections Following Renal Transplantation in Endemic Country.

    K. Jutivorakool, J. Vanichanan, G. Suwanpimolkul, Y. Avihingsanon, N. Townamchai.

    Division of Infectious Diseases, Department of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; Division of Nephrology, Department of Medicine, Chulalongkorn University, Bangkok, Thailand

    Background: Most cases of Tuberculosis (TB) in solid organ transplant recipients are caused by reactivation of a latent infection after initiation of immunosuppressive therapy. This…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences